Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aude G Chapuis

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Advanced Nanobiomed Research|May 6, 2026
Nonviral Gold Nanoparticle-Mediated Delivery of CRISPR-Cas9 Ribonucleoprotein and Long DNA Transgenes Into Primary Blood CellsRachel A Cunningham, Karthikeya S V Gottimukkala, Daniel D Lane, et al.
Blood|March 23, 2011
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivoAude G Chapuis, Corey Casper, Steve Kuntz, et al.
Journal of the American Academy of Dermatology|November 6, 2017
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographicsKelly G Paulson, Song Youn Park, Natalie A Vandeven, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotypeAude G Chapuis, John A Thompson, Kim A Margolin, et al.
JAMA Dermatology|November 14, 2019
Age-Specific Incidence of Melanoma in the United StatesKelly G Paulson, Deepti Gupta, Teresa S Kim, et al.
Heliyon|January 4, 2024
Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinomaJung Hyun Lee, Justin Daho Lee, Kelly Paulson, et al.
Science Immunology|April 4, 2017
Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8<sup>+</sup> T Cells <i>In Vivo</i>Aude G Chapuis, Cindy Desmarais, Ryan Emerson, et al.
The Journal of Experimental Medicine|June 1, 2016
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patientAude G Chapuis, Sylvia M Lee, John A Thompson, et al.
Journal of Immunological Methods|December 31, 2020
Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistryJocelyn H Wright, Li-Ya Huang, Stephanie Weaver, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activityJihoon William Lee, Emily Y Chen, Taylor Hu, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Advanced Nanobiomed Research|May 6, 2026
Nonviral Gold Nanoparticle-Mediated Delivery of CRISPR-Cas9 Ribonucleoprotein and Long DNA Transgenes Into Primary Blood CellsRachel A Cunningham, Karthikeya S V Gottimukkala, Daniel D Lane, et al.
Blood|March 23, 2011
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivoAude G Chapuis, Corey Casper, Steve Kuntz, et al.
Journal of the American Academy of Dermatology|November 6, 2017
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographicsKelly G Paulson, Song Youn Park, Natalie A Vandeven, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotypeAude G Chapuis, John A Thompson, Kim A Margolin, et al.
JAMA Dermatology|November 14, 2019
Age-Specific Incidence of Melanoma in the United StatesKelly G Paulson, Deepti Gupta, Teresa S Kim, et al.
Heliyon|January 4, 2024
Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinomaJung Hyun Lee, Justin Daho Lee, Kelly Paulson, et al.
Science Immunology|April 4, 2017
Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8<sup>+</sup> T Cells <i>In Vivo</i>Aude G Chapuis, Cindy Desmarais, Ryan Emerson, et al.
The Journal of Experimental Medicine|June 1, 2016
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patientAude G Chapuis, Sylvia M Lee, John A Thompson, et al.
Journal of Immunological Methods|December 31, 2020
Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistryJocelyn H Wright, Li-Ya Huang, Stephanie Weaver, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activityJihoon William Lee, Emily Y Chen, Taylor Hu, et al.
Pageof 5